Skip to search
Skip to main content
Skip to first result
Maxine Singer - Profiles in Science
Contact
About
Maxine Singer
The Maxine Singer Papers
Home
The Story
Biographical Overview
Nucleic Acids, the Genetic Code, and Transposable Genetic Elements: A Life in Research
Risk, Regulation, and Scientific Citizenship: The Controversy over Recombinant DNA Research
The Science Administrator as Advocate
Additional Resources
Glossary
Collection Items
search for
Search
Search
Home
Search results
Search
Search Constraints
Start Over
You searched for:
Format
Text
✖
Remove constraint Format: Text
Story Section
Risk, Regulation, and Scientific Citizenship: The Controversy over Recombinant DNA Research
✖
Remove constraint Story Section: Risk, Regulation, and Scientific Citizenship: The Controversy over Recombinant DNA Research
1
-
70
of
70
Sort
by Title (Z-A)
Relevance
Title (A-Z)
Title (Z-A)
Date (oldest to newest)
Date (newest to oldest)
Number of results to display per page
100
per page
per page
10
per page
20
per page
50
per page
100
per page
View results as:
List
List
Gallery
Gallery
Masonry
Masonry
Slideshow
Slideshow
Search Results
1.
Testimony of Maxine Singer before the California State Legislature
Date:
28 January 1977
2.
Testimony by David Baltimore for the Committee on Science and Technology
Date:
30 March 1977
3.
Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
Date:
June 1975
4.
Report of the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
Date:
[29 April 1975]
5.
Proposal for an International Conference on the Social and Ethical Implications of Genetic Engineering
Date:
16 November 1976
6.
Potential Biohazards of Recombinant DNA Molecules [Letter to the Editor of Science]
Date:
26 July 1974
7.
Ordinance for the Use of Recombinant Molecule Technology in the City of Cambridge
Date:
7 February 1977
8.
Ordinance No. 5010: Regulating the Use of Hazardous Biological Research in the City of Berkeley
Date:
21 October 1977
9.
Open Letter to the Asilomar Conference on Hazards of Recombinant DNA
Date:
[February 1975]
10.
Minutes of the Eleventh Meeting of the Executive Recombinant DNA Committee
Date:
25 May 1978
11.
Memorandum from Paul Berg to the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
Date:
9 April 1975
12.
Memorandum from Michael Adler [summarizing the first day of hearings of the Thornton House Subcommittee on Science, Research, and Technology]
Date:
30 March 1977
13.
Memorandum from Maxine Singer to Paul Berg, David Baltimore, Sydney Brenner, and Richard O. Roblin on the latest draft of the Asilomar Reports
Date:
17 April 1975
14.
Memorandum from Maxine Singer to Donald S. Fredrickson
Date:
16 January 1978
15.
Memorandum from Allen Silverstone to the Advisory Committee on the Guidelines for Recombinant DNA
Date:
[1975]
16.
Letter from Wallace P. Rowe to Maxine Singer
Date:
11 August 1976
17.
Letter from Vittorio Sgaramella to Maxine Singer
Date:
27 December 1976
18.
Letter from U.S. Representative Paul G. Rogers to Maxine Singer
Date:
30 March 1977
19.
Letter from Stanley N. Cohen to Maxine Singer
Date:
25 September 1978
20.
Letter from Roy Curtiss III to Maxine Singer
Date:
20 May 1977
21.
Letter from Roy Curtiss III to Donald S. Fredrickson
Date:
12 April 1977
22.
Letter from Roy Curtiss III to Donald S. Fredrickson
Date:
23 September 1978
23.
Letter from Paul Berg to U.S. Senator Harrison Schmitt
Date:
5 January 1979
24.
Letter from Paul Berg to Robert L. Sinsheimer
Date:
30 December 1976
25.
Letter from Paul Berg to Hans L. Kornberg
Date:
12 July 1982
26.
Letter from Milton P. Gordon to Maxine Singer
Date:
10 March 1977
27.
Letter from Maxine Singer to William J. Gartland
Date:
4 October 1984
28.
Letter from Maxine Singer to Willard Gaylin
Date:
30 April 1975
29.
Letter from Maxine Singer to Wallace P. Rowe
Date:
24 August 1976
30.
Letter from Maxine Singer to U.S. Senator John H. Chafee
Date:
31 March 1977
31.
Letter from Maxine Singer to U.S. Representative Richard Ottinger
Date:
26 January 1977
32.
Letter from Maxine Singer to Roy Curtiss III
Date:
3 June 1977
33.
Letter from Maxine Singer to Robert L. Sinsheimer
Date:
7 January 1977
34.
Letter from Maxine Singer to Milton P. Gordon
Date:
22 March 1977
35.
Letter from Maxine Singer to Lorill Brown-Rezanka
Date:
6 June 1977
36.
Letter from Maxine Singer to London Ganning
Date:
13 August 1979
37.
Letter from Maxine Singer to Kathleen K. Schmitz and Karl F. Johnson
Date:
27 November 1978
38.
Letter from Maxine Singer to Joan H. Joshi
Date:
1 December 1976
39.
Letter from Maxine Singer to Howard Raiffa
Date:
8 May 1980
40.
Letter from Maxine Singer to Hans L. Kornberg
Date:
12 August 1982
41.
Letter from Maxine Singer to Francesco Blasi
Date:
3 March 1976
42.
Letter from Maxine Singer to Donald S. Fredrickson
Date:
5 October 1977
43.
Letter from Maxine Singer to Charles Warren
Date:
7 January 1977
44.
Letter from Maxine Singer to Carolyn E. Kemp
Date:
27 November 1978
45.
Letter from Maxine Singer to C. G. Bernhard
Date:
5 July 1977
46.
Letter from London Ganning to Maxine Singer
Date:
24 July 1979
47.
Letter from Joshua Lederberg to U.S. Senators Alan Cranston and Samuel Ichiye Hayakawa
Date:
[ca. 9 June 1977]
48.
Letter from James L. Sullivan, City Manager, City of Cambridge, Massachusetts to the Mayor and City Council
Date:
6 August 1976
49.
Letter from Howard Raiffa to Maxine Singer
Date:
17 April 1980
50.
Letter from Donald S. Fredrickson to Daniel E. Koshland, Jr
Date:
23 August 1976
51.
Letter from David S. Hogness to DeWitt Stetten, Jr
Date:
26 January 1977
52.
Letter from David Baltimore to Fred C. Ikle
Date:
22 May 1975
53.
Letter from Charles Warren and Barry Keene to Maxine Singer
Date:
29 December 1976
54.
Letter from Carolyn E. Kemp to Maxine Singer
Date:
31 October 1978
55.
Interview with Dr. Maxine F. Singer [on recombinant DNA research and NIH]
Date:
28 June 1979
56.
Cover memorandum about a Berkeley, California biohazards ordinance
Date:
[1977]
57.
Committee on Risk and Decision Making
Date:
[17 April 1980]
58.
Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines
Date:
[29 April 1975]
59.
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
Date:
[15 April 1975]
60.
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
Date:
[Spring 1975]
61.
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
Date:
[29 April 1975]
62.
Appendix H: Provisional Statement of the Conference Proceedings
Date:
[27 February 1975]
63.
Appendix F: Cloned Eukaryotic DNA
Date:
[29 April 1975]
64.
Appendix F: Cloned Eukaryotic DNA
Date:
[25 February 1975]
65.
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
Date:
[29 April 1975]
66.
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
Date:
[25 February 1975]
67.
Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms
Date:
24 February 1975
68.
Appendix C: Program of the International Conference on Recombinant DNA Molecules
Date:
[23 February 1975]
69.
A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research
Date:
[March 1977]
70.
A Statement
Date:
20 December 1976